Rafferty Asset Management, LLC Ardelyx, Inc. Transaction History
Rafferty Asset Management, LLC
- $22.9 Billion
- Q1 2025
A detailed history of Rafferty Asset Management, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 393,428 shares of ARDX stock, worth $2.01 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
393,428
Previous 534,743
26.43%
Holding current value
$2.01 Million
Previous $2.76 Million
30.14%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding ARDX
# of Institutions
228Shares Held
165MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$127 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$89.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15MShares$76.5 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$56.9 Million0.07% of portfolio
-
State Street Corp Boston, MA10.2MShares$51.9 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $789M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...